• Latest Posts

Scottish Biotech and Bluebird Bio to Develop Next Generation CAR-T Cells

Interview 4 Dec 2017

Meet the CEO Leading Italy’s Charge to Become a Major Biotech Player

This British Biotech Could Treat T-Cell Lymphoma without Leaving the Body Unprotected

The FDA Approves a Second CAR-T Therapy, Cheaper than Novartis’

Infographics 18 Oct 2017

Infographic: What is CAR-T Cell Therapy & How Does it Fight Cancer?

British Biotech Pockets Massive Series C for its CAR-T Cancer Therapies

ADVERTISEMENT

CAR-T is Nearly Here: How Will It Be Delivered?

Interview 6 Sep 2017

The CAR-T Race is Far from Over: This CEO is Exploring a New Avenue

The FDA Approves the First CAR-T Cell Therapy for Cancer

Gilead’s €10Bn Buyout of Kite Pharma Shakes European CAR-T Stocks

Novartis largely dodged deaths from its CAR-T therapy, but FDA still has safety concerns

Cutting Through the BS in Biopharma: How To Spot Hype

ADVERTISEMENT